Prophylactic effect of somatostatin in preventing Post-ERCP pancreatitis: an updated meta-analysis
Background/Aims: Somatostatin is regarded as a prophylactic agent on post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP), but studies are still controversial. Materials and Methods: Electronic databases, including PubMed, EMBASE, the Cochrane library, and the Science Citati...
Main Authors: | Xie Qin, Wen S Lei, Zhang X Xing, Feng Shi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
Series: | The Saudi Journal of Gastroenterology |
Subjects: | |
Online Access: | http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2015;volume=21;issue=6;spage=372;epage=378;aulast=Qin |
Similar Items
-
Role of somatostatin for preventing post-ERCP pancreatitis: an update meta-analysis
by: Jing Hu, et al.
Published: (2016-12-01) -
Association of Helicobacter pylori infection with somatostatin deficiency and its relation to post-endoscopic retrograde cholangiopancreatography pancreatitis
by: Madiha Abd-Elghany El-Ziny, et al.
Published: (2018-01-01) -
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline-Updated June 2014
by: LI Xiaoqing
Published: (2014-12-01) -
Post-ERCP pancreatitis and its related factors: A prospective study in Cipto Mangunkusumo National General Hospital
by: Dadang Makmun, et al.
Published: (2015-10-01) -
Three-hour post-ERCP amylase level: a useful indicator for early prediction of post-ERCP pancreatitis
by: Ze-Hui Lv, et al.
Published: (2020-04-01)